Citadel Advisors »

Fate Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 2.7M 3.74
2023-09-30 $4.3M 2.0M 2.12
2023-06-30 $11M 2.3M 4.76
2023-03-31 $9.7M 1.7M 5.70
2022-12-31 $15M 1.5M 10.09
2022-06-30 $9.8M 396k 24.78
2022-03-31 $18M 463k 38.77
2021-12-31 $14M 234k 58.51
2021-09-30 $13M 225k 59.25
2021-06-30 $64M 737k 86.78
2021-03-31 $78M 943k 82.46
2020-12-31 $107M 1.2M 90.92
2020-09-30 $106M 2.7M 39.97
2020-06-30 $114M 3.3M 34.31
2020-03-31 $51M 2.3M 22.21
2019-12-31 $17M 890k 19.57
2019-09-30 $9.1M 588k 15.53
2019-06-30 $479k 24k 20.30
2019-03-31 $16M 924k 17.57
2018-12-31 $16M 1.3M 12.83
2018-09-30 $13M 806k 16.32
2018-06-30 $1.4M 125k 11.34
2017-12-31 $63k 10k 6.08
2017-03-31 $63k 14k 4.58
2015-12-31 $49k 15k 3.39